Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

4,880 results found

Article
Ask Lexy

Bryan Cave Leighton Paisner LLP | Hong Kong | 6 Jan 2022

Private actions relating to alleged contraventions of the Competition Ordinance of Hong Kong: the first reported Hong Kong judgments - Part Two

On 12 October 2021, the Competition Tribunal (“Tribunal”) handed down its judgment on the merits of the first private action in Hong Kong for a…
Article
Ask Lexy

Association of Corporate Counsel | Global, USA | 22 Oct 2021

ACC Chief Legal Officers 2021 Survey: key findings

ACC, in partnership with Exterro, the exclusive ACC Alliance Partner for eDiscovery, data privacy, and cybersecurity, presents the results of the…
Analysis PRO In-house
Ask Lexy

Lexology PRO | Central & South America, European Union, France, etc. | 9 Aug 2021

CMA to probe “exploitative” coronavirus testing kit prices

The UK’s antitrust watchdog has agreed to advise the government on whether travellers are being charged excessive prices for covid-19 tests after the health secretary asked it to conduct a “rapid high-level review”.
Analysis PRO In-house
Ask Lexy

Lexology PRO | European Union, United Kingdom | 5 Aug 2021

CMA reaccuses Pfizer and Flynn of excessive pricing

The UK’s Competition and Markets Authority has accused Pfizer and Flynn Pharma of charging unfairly high prices for an anti-epilepsy medication, 17 months after an appellate court ordered the agency to redo parts of its initial probe into the drugmakers.
Analysis PRO In-house
Ask Lexy

Lexology PRO | Asia-Pacific, Hong Kong | 3 Aug 2021

Hong Kong issues guidance on trade associations

Hong Kong’s antitrust authority has warned that overly strict membership criteria for trade associations can be “especially damaging” to individuals or businesses and run afoul of the territory’s competition rules.
Analysis PRO In-house
Ask Lexy

Lexology PRO | United Kingdom | 29 Jul 2021

CMA doles out £100 million in fines for excessive pricing of thyroid drug

The UK’s Competition and Markets Authority has hit Advanz Pharma and its two former owners with more than £100 million in fines for overcharging the country’s national health service for thyroid medication liothyronine over an eight-year period.
Analysis PRO
Ask Lexy

Lexology PRO | Asia-Pacific, Australia, Canada, etc. | 27 Jul 2021

Compliance management: key updates (21 – 27 Jul)

The UK, Australia, Canada, and the EU consult on new legislation and guidance, the US issues warnings over doing business in Hong Kong, and plans by Nigeria and India to launch central bank digital currencies – plus other key compliance management updates.
Analysis PRO In-house
Ask Lexy

Lexology PRO | Australia, Canada, European Union, etc. | 26 Jul 2021

Aon/Willis Towers Watson abandoned amid DOJ litigation

Aon and Willis Towers Watson have called off plans to form the world’s largest insurance broker, citing the US Department of Justice’s opposition to the deal.
Analysis PRO In-house
Ask Lexy

Lexology PRO | Belgium, European Union, United Kingdom | 23 Jul 2021

UK’s electric car charging study jumpstarts antitrust probe

The UK’s antitrust enforcer is investigating exclusivity agreements between an electric vehicle charging provider and three major UK service station operators, after a market study found a lack of chargepoints may prevent drivers from switching to electric cars.
Analysis PRO
Ask Lexy

Lexology PRO | Asia-Pacific, Australia, Denmark, etc. | 21 Jul 2021

Anti-corruption: key compliance updates (8 – 21 Jul)

New whistleblower legislation in Denmark, a new anti-corruption strategy in France, and the US Air Force’s fight against acquisition fraud– plus enforcement actions from around the world and other key anti-corruption updates.
Previous page 1 2 3 ...